Author:
Chen Yuhan,Wang Jimeng,Yi Meixi,Xu Hongteng,Liang Hailun
Abstract
AbstractCOVID-19 is a continuing threat to global public health security. For elderly people, timely and effective vaccination reduces infection rates in this group and safeguards their health. This paper adopted an offline Discrete Choice Experiment (DCE) to research the preference for COVID-19 vaccination amongst Chinese adults aged 50 years and above. Through multinomial logistic regression analysis, our DCE leverages five attributes—the risk of adverse reactions, protective duration, injection doses, injection period, and effectiveness—each of which is split into three to four levels. The risk of adverse reaction and the protective duration were demonstrated to be determinants of vaccination preference. Moreover, it was found that socio demographic factors like region, self-health assessment and the number of vaccinated household members can strengthen or weaken the effects of vaccine attributes. In conclusion, the preferences of the elderly population should be considered when developing COVID-19 vaccination programs for this population in China. Accordingly, the results may provide useful information for policymakers to develop tailored, effectively vaccination strategies.
Funder
Beijing Social Science Foundation
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Li, Y. D. et al. Coronavirus vaccine development: From SARS and MERS to COVID-19. J. Biomed. Sci. 27(1), 104. https://doi.org/10.1186/s12929-020-00695-2 (2020).
2. WHY WE NEED COVAX. https://www.gavi.org/covax-facility (2021).
3. Chow, E. J., Doyle, J. D. & Uyeki, T. M. Influenza virus-related critical illness: Prevention, diagnosis, treatment. Crit. Care 23(1), 214. https://doi.org/10.1186/s13054-019-2491-9PMID:31189475 (2019).
4. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. https://www.cdc.gov/mmwr/volumes/70/wr/mm7037e1.htm (2021).
5. Leng, A. et al. Individual preferences for COVID-19 vaccination in China. Vaccine 39(2), 247–254. https://doi.org/10.1016/j.vaccine.2020.12.009 (2021).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献